NO20016052L - IL-8 receptor antagonists - Google Patents

IL-8 receptor antagonists

Info

Publication number: NO20016052L
Authority: NO; Norway
Prior art keywords: receptor antagonists; antagonists; receptor
Prior art date: 1999-06-16

Application number

NO20016052A

Other languages

Norwegian (no)

Other versions

NO20016052D0 (en

Inventor

Katherine Louisa Widdowson

Gregory M Benson

Melvin C Rutledge

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-16

Filing date

2001-12-11

Publication date

2001-12-11

2001-12-11 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2001-12-11 Publication of NO20016052D0 publication Critical patent/NO20016052D0/en

2001-12-11 Publication of NO20016052L publication Critical patent/NO20016052L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Communicable Diseases (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Diabetes (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20016052A 1999-06-16 2001-12-11 IL-8 receptor antagonists NO20016052L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US14002499P	1999-06-16	1999-06-16
PCT/US2000/016506 WO2000076501A1 (en)	1999-06-16	2000-06-15	Il-8 receptor antagonists

Publications (2)

Publication Number	Publication Date
NO20016052D0 NO20016052D0 (en)	2001-12-11
NO20016052L true NO20016052L (en)	2001-12-11

Family

ID=22489379

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20016052A NO20016052L (en)	1999-06-16	2001-12-11	IL-8 receptor antagonists

Country Status (19)

Country	Link
EP (1)	EP1185265A4 (en)
JP (1)	JP2003501463A (en)
KR (1)	KR20020015347A (en)
CN (1)	CN1356899A (en)
AR (1)	AR024350A1 (en)
AU (1)	AU766235B2 (en)
BR (1)	BR0011122A (en)
CA (1)	CA2377386A1 (en)
CO (1)	CO5190696A1 (en)
CZ (1)	CZ20014472A3 (en)
HU (1)	HUP0201582A3 (en)
IL (1)	IL145762A0 (en)
MX (1)	MXPA01013005A (en)
NO (1)	NO20016052L (en)
NZ (1)	NZ514696A (en)
PL (1)	PL352213A1 (en)
TR (1)	TR200103638T2 (en)
WO (1)	WO2000076501A1 (en)
ZA (1)	ZA200109480B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4664074B2 (en)	2002-10-09	2011-04-06	シェーリングコーポレイション	Thiadiazole dioxide and thiadiazole oxide as CXC-chemokine receptor ligand and CC-chemokine receptor ligand
DE10334309A1 (en) *	2003-07-28	2005-03-03	Aventis Pharma Deutschland Gmbh	Substituted thiazole-Benzoisothiazoldioxidderivate, processes for their preparation and their use
US7094794B2 (en)	2003-07-28	2006-08-22	Sanofi-Aventis Deutschland Gmbh	Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
DE602004017623D1 (en)	2003-08-21	2008-12-18	Osi Pharm Inc	N-SUBSTITUTED PYRAZOLYL-AMIDYL-BENZIMIDAZOLYL C-KIT INHIBITORS
KR20060121818A (en)	2003-08-21	2006-11-29	오에스아이 파마슈티컬스, 인코포레이티드	N-substituted benzimidazolyl C-VIT inhibitors
US7442709B2 (en)	2003-08-21	2008-10-28	Osi Pharmaceuticals, Inc.	N3-substituted imidazopyridine c-Kit inhibitors
WO2005066147A1 (en)	2003-12-19	2005-07-21	Schering Corporation	Thiadiazoles as cxc- and cc- chemokine receptor ligands
AU2005299771A1 (en)	2004-10-21	2006-05-04	High Point Pharmaceuticals, Llc	Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use
KR20070086865A (en)	2004-12-01	2007-08-27	오에스아이 파마슈티컬스, 인코포레이티드	N-substituted benzimidazolyl C-VIT inhibitors and combinatorial benzimidazole libraries
US8648086B2 (en)	2009-08-24	2014-02-11	Ascepion Pharmaceuticals, Inc.	5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
EP2377850A1 (en)	2010-03-30	2011-10-19	Pharmeste S.r.l.	TRPV1 vanilloid receptor antagonists with a bicyclic portion
CN102060780B (en)	2010-12-27	2014-11-05	雅本化学股份有限公司	Preparation method of 2-(N-substituted).-aminobenzimidazole derivative
CN111116502A (en) *	2018-10-30	2020-05-08	中国石油化工股份有限公司	One-step method for synthesizing benzotriazole

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA921120B (en) *	1991-02-19	1993-01-27	Smithkline Beecham Corp	Cytokine inhibitors
EP0991406A4 (en) *	1997-01-23	2000-12-13	Smithkline Beecham Corp	Il-8 receptor antagonists

2000
- 2000-06-13 CO CO00043846A patent/CO5190696A1/en not_active Application Discontinuation
- 2000-06-14 AR ARP000102922A patent/AR024350A1/en not_active Application Discontinuation
- 2000-06-15 KR KR1020017016144A patent/KR20020015347A/en not_active Withdrawn
- 2000-06-15 PL PL00352213A patent/PL352213A1/en not_active Application Discontinuation
- 2000-06-15 CN CN00809090A patent/CN1356899A/en active Pending
- 2000-06-15 WO PCT/US2000/016506 patent/WO2000076501A1/en not_active Ceased
- 2000-06-15 HU HU0201582A patent/HUP0201582A3/en unknown
- 2000-06-15 TR TR2001/03638T patent/TR200103638T2/en unknown
- 2000-06-15 MX MXPA01013005A patent/MXPA01013005A/en unknown
- 2000-06-15 EP EP00941455A patent/EP1185265A4/en not_active Withdrawn
- 2000-06-15 BR BR0011122-8A patent/BR0011122A/en not_active IP Right Cessation
- 2000-06-15 IL IL14576200A patent/IL145762A0/en unknown
- 2000-06-15 JP JP2001502834A patent/JP2003501463A/en not_active Withdrawn
- 2000-06-15 NZ NZ514696A patent/NZ514696A/en unknown
- 2000-06-15 AU AU56161/00A patent/AU766235B2/en not_active Ceased
- 2000-06-15 CA CA002377386A patent/CA2377386A1/en not_active Abandoned
- 2000-06-15 CZ CZ20014472A patent/CZ20014472A3/en unknown
- 2000-11-16 ZA ZA200109480A patent/ZA200109480B/en unknown
2001
- 2001-12-11 NO NO20016052A patent/NO20016052L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
IL145762A0 (en)	2002-07-25
CZ20014472A3 (en)	2002-06-12
AU5616100A (en)	2001-01-02
WO2000076501A1 (en)	2000-12-21
CA2377386A1 (en)	2000-12-21
NO20016052D0 (en)	2001-12-11
HUP0201582A3 (en)	2003-02-28
JP2003501463A (en)	2003-01-14
KR20020015347A (en)	2002-02-27
CO5190696A1 (en)	2002-08-29
AU766235B2 (en)	2003-10-09
EP1185265A1 (en)	2002-03-13
ZA200109480B (en)	2002-11-18
MXPA01013005A (en)	2002-07-02
EP1185265A4 (en)	2004-02-04
HUP0201582A2 (en)	2002-12-28
AR024350A1 (en)	2002-10-02
PL352213A1 (en)	2003-08-11
NZ514696A (en)	2004-03-26
BR0011122A (en)	2002-02-26
TR200103638T2 (en)	2002-04-22
CN1356899A (en)	2002-07-03

Publication	Publication Date	Title
NO20001100D0 (en)	2000-03-03	IL-8 receptor antagonists
NO20025754L (en)	2002-11-29	IL-8 Receptor Antagonists
DE60216229D1 (en)	2007-01-04	IL-8 receptor antagonists
NO20016053D0 (en)	2001-12-11	IL-8 receptor antagonists
DE60112051D1 (en)	2005-08-25	IL-8 RECEPTOR ANTAGONISTS
ATE353215T1 (en)	2007-02-15	IL-8 RECEPTOR ANTAGONISTS
NO20016052L (en)	2001-12-11	IL-8 receptor antagonists
DE69838874D1 (en)	2008-01-31	IL-8 RECEPTOR ANTAGONISTS
DK1180028T3 (en)	2007-05-21	IL-8 receptor antagonists
NO20024554D0 (en)	2002-09-23	IL-8 receptor antagonists
DE69824837D1 (en)	2004-08-05	IL-8 RECEPTOR ANTAGONISTS
ATE303370T1 (en)	2005-09-15	IL-8 RECEPTOR ANTAGONISTS
NO20015774L (en)	2001-11-27	IL-8 receptor antagonists
NO20024367L (en)	2002-10-22	IL-8 receptor antagonists
NO20016102D0 (en)	2001-12-14	IL-8 receptor antagonists
NO20016065L (en)	2001-12-12	IL-8 receptor antagonists
NO20024366L (en)	2002-10-09	IL-8 receptor antagonists
NO20010353L (en)	2001-01-22	IL-8 receptor antagonist
SE0003996D0 (en)	2000-11-01	receptor Antagonists

Legal Events

Date	Code	Title	Description
2008-01-21	FC2A	Withdrawal, rejection or dismissal of laid open patent application